iCCaRE Consortium Pilot Project 1: Feasibility of a Point of Prostate Cancer Diagnosis Intervention for Newly Diagnosed Black Men

Recruiting now

Conditions studied: Prostate Carcinoma

In brief

This study is being done to determine the acceptance and effectiveness of a virtual robot assistant model at a urology clinic.

Key facts

Study ID

NCT06535802

Run by

Mayo Clinic

People needed

53

Starts

2023-11-20

Expected to finish

2026-12-01

Last updated by the study team

2026-01-20

Who can join

Age: any, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• AIM 1: iCCaRE Consortium consumer advocates
• Clinicians who are part of the Translational Research \& Clinical Intervention Services (TRaCIS)
• AIM 2 ALPHA TESTING: iCCaRE consumer advocates [2 Community Advisory Board (CAB) and 1 non-CAB]
• AIM 2 BETA TESTING-PATIENTS:
• An African American/Black male
• A patient who has been diagnosed with prostate cancer in Florida at any time in their life, and/or within the previous 6 months has had an abnormal Prostate-Specific Antigen (PSA) lab value and/or Digital Rectal Examination (DRE)
• Minimum age of 30 years old
• Consent to participating in the intervention

You may not qualify if…

• AIM 2 BETA TESTING-PATIENTS:
• Patients who are not African American/Black males
• Patients not diagnosed with prostate cancer in Florida at any time in their life, or within the previous 6 months has not had a normal PSA lab value and/or DRE
• Older than 80 years old
• Are not willing to consent

Where it is running

• Mayo Clinic in Florida — Jacksonville, Florida, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.